Huey-jiun Ko
Kaohsiung, KHQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
6-Gingerol overcomes TMZ resistance in GBM by suppressing EMT and cell migration via the PI3K/Akt/β-catenin/c-Myc pathway.
Journal: International immunopharmacology
Published: April 13, 2025
Dehydroepiandrosterone suppresses human colorectal cancer progression through ER stress-mediated autophagy and apoptosis in a p53-independent manner.
Journal: Frontiers in pharmacology
Published: July 14, 2024
6-Gingerol Induced Apoptosis and Cell Cycle Arrest in Glioma Cells via MnSOD and ERK Phosphorylation Modulation.
Journal: Biomolecules & therapeutics
Published: May 27, 2024
The mystery of phospho-Drp1 with four adaptors in cell cycle: when mitochondrial fission couples to cell fate decisions.
Journal: Cell cycle (Georgetown, Tex.)
Published: December 06, 2023
GSKIP modulates cell aggregation through EMT/MET signaling rather than differentiation in SH-SY5Y human neuroblastoma cells.
Journal: Journal of cell communication and signaling
Published: August 03, 2022
BMX, a specific HDAC8 inhibitor, with TMZ for advanced CRC therapy: a novel synergic effect to elicit p53-, β-catenin- and MGMT-dependent apoptotic cell death.
Journal: Cell communication and signaling : CCS
Published: July 29, 2022
Supplementary Motor Area Syndrome after Removal of an Unusual Extensive Parasagittal Meningioma: Analysis of Twelve Reported Cases.
Journal: Medicina (Kaunas, Lithuania)
Published: July 29, 2022
Prevention of Compression Fracture in Osteoporosis Patients under Minimally Invasive Trans-Foraminal Lumbar Interbody Fusion with Assistance of Bone-Mounted Robotic System in Two-Level Degenerative Lumbar Disease.
Journal: Medicina (Kaunas, Lithuania)
Published: April 22, 2022
Many faces and functions of GSKIP: a temporospatial regulation view.
Journal: Cellular signalling
Published: April 13, 2022
Deciphering the evolution of composite-type GSKIP in mitochondria and Wnt signaling pathways.
Journal: PloS one
Published: June 20, 2021
NBM-BMX, an HDAC8 Inhibitor, Overcomes Temozolomide Resistance in Glioblastoma Multiforme by Downregulating the β-Catenin/c-Myc/SOX2 Pathway and Upregulating p53-Mediated MGMT Inhibition.
Journal: International journal of molecular sciences
Published: May 14, 2021
Last Updated: 09/26/2026